86 related articles for article (PubMed ID: 36051540)
1. Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study.
Sitanggang JS; Siregar KB; Sitanggang HH; Sprinse Vinolina N
F1000Res; 2021; 10():975. PubMed ID: 36051540
[No Abstract] [Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data.
Kong X; Qi Y; Huang J; Zhao Y; Zhan Y; Qin X; Qi Z; Atanda AJ; Zhang L; Wang J; Fang Y; Jia P; Golozar A; Zhang L; Jiang Y
Cancer Lett; 2021 Jun; 508():30-46. PubMed ID: 33757803
[TBL] [Abstract][Full Text] [Related]
4. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.
Prakash A; Singh H; Sarma P; Bhattacharyya A; Dhibar DP; Balaini N; Shree R; Goyal M; Modi M; Medhi B
Sci Rep; 2021 Jun; 11(1):12888. PubMed ID: 34145351
[TBL] [Abstract][Full Text] [Related]
5. Distinct Symptoms and Underlying Comorbidities with Latitude and Longitude in COVID-19: A Systematic Review and Meta-Analysis.
Tian Y; Wu Q; Li H; Wu Q; Xie Y; Li L; Chen H
Can Respir J; 2022; 2022():6163735. PubMed ID: 35096211
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
8. Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis.
Kaur H; Thakur JS; Paika R; Advani SM
Asian Pac J Cancer Prev; 2021 May; 22(5):1333-1349. PubMed ID: 34048161
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis.
Zhang H; Han H; He T; Labbe KE; Hernandez AV; Chen H; Velcheti V; Stebbing J; Wong KK
J Natl Cancer Inst; 2021 Apr; 113(4):371-380. PubMed ID: 33136163
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
11. Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.
Gülsen A; König IR; Jappe U; Drömann D
Respirology; 2021 Jun; 26(6):552-565. PubMed ID: 33955623
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis.
Noor FM; Islam MM
J Community Health; 2020 Dec; 45(6):1270-1282. PubMed ID: 32918645
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
[TBL] [Abstract][Full Text] [Related]
15. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis.
Singh J; Malik P; Patel N; Pothuru S; Israni A; Chakinala RC; Hussain MR; Chidharla A; Patel H; Patel SK; Rabbani R; Patel U; Chugh S; Kichloo A
Clin Exp Med; 2022 Feb; 22(1):125-135. PubMed ID: 33891214
[TBL] [Abstract][Full Text] [Related]
16. Increase in COVID-19 cases and case-fatality and case-recovery rates in Europe: A cross-temporal meta-analysis.
Karadag E
J Med Virol; 2020 Sep; 92(9):1511-1517. PubMed ID: 32437052
[TBL] [Abstract][Full Text] [Related]
17. Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis.
Tian Y; Qiu X; Wang C; Zhao J; Jiang X; Niu W; Huang J; Zhang F
Int J Cancer; 2021 Jan; 148(2):363-374. PubMed ID: 32683687
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
19. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
20. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
COVID-19 Forecasting Team
Lancet; 2022 Apr; 399(10334):1469-1488. PubMed ID: 35219376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
